Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 28 citing Berger: The ethics of deactivating implanted cardioverter defibrillators. (0.08 sec) 

HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic …

- pubget.com [PDF] 
F MD, JG Howlett, J Kautzner, CJ Love - Europace, 2008 - Eur Heart Rhythm Assoc
This document represents expert consensus concerning the Monitoring of
Cardiovascular Implantable Electronic Devices (CIEDs). The views expressed are
of the international writing group consisting of seven cardiac ...
Cited by 24 - Related articles - All 6 versions

Palliative care and hospice in advanced heart failure

- uab.edu [PDF] 
B Stuart - Journal of Palliative Medicine, 2007 - liebertonline.com
This paper provides an evidence-based review of the principles underlying
palliative care for heart failure (HF), including its pathogenesis, staging,
assessment, prognosis, and treatment. Approaches to advanced care planning, ...
Cited by 16 - Related articles - BL Direct - All 4 versions

End-of-life and other ethical issues related to pacemaker and defibrillator use in the elderly


LL Basta - American Journal of Geriatric Cardiology, 2006 - interscience.wiley.com
In the past decade, the rate of implantation of pacemakers and
cardioverter-defibrillators in the elderly with cardiac impairment has soared.
As patients near the end of life, interventions become more complicated and ...
Cited by 7 - Related articles - BL Direct - All 3 versions

[PDF] End-of-life decisions in ICD patients with malignant tumors


R Kobza, P Erne - Pace-Pacing and Clinical Electrophysiology, 2007 - ksl.ch
Introduction The use of implantable cardioverter-defi- brillators (ICDs) is
established as both primary and secondary prophylaxis of sudden cardiac death.
As recent studies have shown a survival benefit mainly in patients with a ...
Cited by 7 - Related articles - View as HTML - BL Direct - All 6 versions

End-of-life care in the treatment of heart failure in the elderly

- chhs-scsc.ca [PDF] 
JA McClung - Heart Failure Clinics, 2007 - Elsevier
The American Geriatrics Society position statement on the care of dying patients
opens by stating that, “providing excellent, humane care to patients near the
end of life, when curative means are either no longer possible or no longer ...
Cited by 5 - Related articles - All 19 versions

Pacemakers and defibrillators: recent and ongoing studies that impact the elderly


C Martinez, A Tzur, H Hrachian, J Zebede, … - AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY, 2006 - interscience.wiley.com
Since the first implantation of a cardiac pacemaker in the second half of the
20th century, there have been evolutionary and revolutionary advances in the
technology developed for patients with heart rhythm disturbances. These ...
Cited by 4 - Related articles - BL Direct - All 2 versions

Withdrawal of cardiac medications and devices

- critcaremed.com
DLMH Wiegand, PG Kalowes - AACN Advanced Critical Care, 2007 - journals.lww.com
Withdrawal of life-sustaining therapies such as cardiac medications, pacemakers,
internal cardioverter defibrillators, and ventricular assist devices occurs in
patients with advanced cardiac disease as goals of treatment transition ...
Cited by 4 - Related articles - BL Direct - All 3 versions

Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes


PS Mueller, SM Jenkins, KA Bramstedt, DL … - Pace-Pacing and Clinical Electrophysiology, 2008 - medscape.com
Patients with implanted cardiac devices avoid death caused by cardiac conduction
abnormalities or malignant dysrhythmias. These patients may later develop
terminal illness due to a noncardiac disease or progressive heart failure, ...
Cited by 2 - Related articles - BL Direct - All 6 versions

Palliative care issues in heart failure# 144


GM Reisfield, GR Wilson - Journal of Palliative Medicine, 2007 - liebertonline.com
• Optimize dose of oral loop diuretic (eg, furosemide). Doses of up to 4000
mg/d have been found to be safe and effective. • Change to
intravenous/subcutaneous route. Intravenous boluses can produce symptom re- ...
Cited by 2 - Related articles - BL Direct - All 3 versions

Within you/without you: biotechnology, ontology, and ethics

- nih.gov
DP Sulmasy - Journal of General Internal Medicine, 2008 - Springer
Page 1. Within You / Without You: Biotechnology, Ontology, and Ethics Daniel P.
Sulmasy, OFM, MD, PhD 1,2 1 John J. Conley Department of Ethics, St. ...
Cited by 2 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google